CTLA-4, a T cell surface receptor, negatively regulates immune response, and antibody drugs enhance anti-tumor immune response. LAG3, Lymphocyte activation gene 3, which inhibits T cell function, is a target of the new generation of immune checkpoint inhibitors.
At Alpha Lifetech, we are committed to delivering only the highest quality bispecific antibodies. Each product undergoes rigorous testing to ensure its high activity, purity, and consistency.